SEC Form 4 · accession 0001140361-15-000133
Coherus Oncology, Inc. · CHRS
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
V Bryan Lawlis
Director
Period of report
Dec 31, 2014
Accepted (ET)
Jan 2, 2015 · 5:17 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001512762
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy)F1 | $16.32 | Dec 31, 2014 | A | 15,000 | A | — | Dec 30, 2024 | Common Stock | 15,000 | 15,000 | D |
Explanation of responses
- F1The stock option vests pursuant to the following schedule: One Forty Eighth (1/48th) of the option vests and becomes exercisable in successive, equal monthly installments measured from June 30, 2014, subject to Reporting Person's continued service relationship with the Issuer on each such vesting date.